These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21095626)

  • 1. Renal outcome of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Nomura S; Taki F; Tamagaki K; Futatsuyama M; Nishihara S; Anzai H; Nishi Y; Takao N; Hayashida N; Komatsu Y
    Int J Cardiol; 2011 Jan; 146(2):295-6. PubMed ID: 21095626
    [No Abstract]   [Full Text] [Related]  

  • 2. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.
    Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD
    Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-based percutaneous coronary intervention in a patient with renal insufficiency.
    Bokhari SW; Wen YH; Winters RJ
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):358-61. PubMed ID: 12594702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention under the rigid restriction of contrast media dose in patients with chronic renal insufficiency.
    Yamamoto E; Takano H; Takayama M
    J Invasive Cardiol; 2006 Jun; 18(6):E169-72. PubMed ID: 16775894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease.
    Neyra JA; Shah S; Mooney R; Jacobsen G; Yee J; Novak JE
    Nephrol Dial Transplant; 2013 Jun; 28(6):1463-71. PubMed ID: 23585585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury.
    Panagiotou A; Trendelenburg M; Heijnen IAFM; Moser S; Bonati LH; Breidthardt T; Fahrni G; Kaiser C; Jeger R; Osthoff M
    JACC Cardiovasc Interv; 2020 Apr; 13(7):833-842. PubMed ID: 32171721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.
    Subedi B; Siddique MA; Zaman SM; Hasan MI; Arzu J; Awal A; Fatema K
    Mymensingh Med J; 2011 Apr; 20(2):270-4. PubMed ID: 21522099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Coronary Sinus Aspiration During Coronary Angiography to Attenuate the Risk of Contrast-Induced Acute Kidney Injury in Predisposed Patients.
    Diab OA; Helmy M; Gomaa Y; El-Shalakany R
    Circ Cardiovasc Interv; 2017 Jan; 10(1):e004348. PubMed ID: 28049622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
    Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and contrast-induced acute kidney injury with coronary angiography.
    Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
    Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible acute kidney injury following contrast exposure and the risk of long-term mortality.
    Goldenberg I; Chonchol M; Guetta V
    Am J Nephrol; 2009; 29(2):136-44. PubMed ID: 18753738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure.
    Tamura A; Goto Y; Miyamoto K; Naono S; Kawano Y; Kotoku M; Watanabe T; Kadota J
    Am J Cardiol; 2009 Oct; 104(7):921-5. PubMed ID: 19766757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modern axis of peri-procedural evil.
    Hillegass WB
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):56-7. PubMed ID: 19530189
    [No Abstract]   [Full Text] [Related]  

  • 16. [Percutaneous transluminal coronary angioplasty, x-ray contrast researches and contrast-induced nephropathy in geriatrics].
    Ar'ev AL; Chesnokov AA
    Adv Gerontol; 2013; 26(3):511-7. PubMed ID: 24640703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcysteine for the prevention of renal outcomes in patients with diabetes mellitus undergoing coronary and peripheral vascular angiography: a substudy of the acetylcysteine for contrast-induced nephropathy trial.
    Berwanger O; Cavalcanti AB; Sousa AM; Buehler A; Castello-Júnior HJ; Cantarelli MJ; Mangione JA; Bergo RR; São Thiago LE; Nunes PM; da Motta PA; Kodama A; Victor E; Carvalho VO; Sousa JE;
    Circ Cardiovasc Interv; 2013 Apr; 6(2):139-45. PubMed ID: 23572490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function.
    Kini AS; Sarkar K; Rafael OC; Jakkula M; Kaplish D; Lee P; Suleman J; Krishnan P; Kim MC; Sharma SK
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):49-55. PubMed ID: 19288579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
    Karimi Galougahi K; Mintz GS; Karmpaliotis D; Ali ZA
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):E85-E89. PubMed ID: 28303645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.